James Hall
Chief Executive Officer at Betagenon Sweden AB
James Hall active positions
| Companies | Position | Start | End |
|---|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Chief Executive Officer | 2021-05-26 | - |
Career history of James Hall
Training of James Hall
| University of Oxford | Doctorate Degree |
Statistics
International
| Sweden | 2 |
| United Kingdom | 2 |
Operational
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
- Stock Market
- Insiders
- James Hall
- Experience
